EKO / TSX
MONTREAL, March 17 /CNW Telbec/ - Noveko International Inc. ("the Company") is pleased to announce that its subsidiary Epurair Inc. has signed an agreement with the Jewish General Hospital ("JGH"), one of the largest and busiest hospitals in the province, in order to equip one of its pavilions with filters incorporating the Noveko(TM) antimicrobial filtration technology. This 30-month agreement covers the supply of the filters and their cleaning. The parties have agreed to keep the financial terms and conditions of this agreement confidential.
"We are proud that the Jewish General Hospital, located in Montreal and recognized as a leading healthcare and research institution in Quebec thanks notably to the excellent medical treatments it provides, is the first hospital to use our antimicrobial filtration solution. We believe that this agreement will further stimulate the commercialization of our filters in various institutional settings," indicated Alain Bolduc, President and Chief Operating Officer of the Company.
Epurair(TM) filters incorporating the Noveko(TM) antimicrobial filtration technology consist of four layers of synthetic fibre that are fully leak-proof and offer an excellent resistance to temperature variations. Their superior filtration effectiveness also enables users to achieve energy savings. Thanks to their great durability and the fact that they are entirely washable and recyclable, the number of filters used and the costs associated with their replacement are reduced considerably, thereby making them a first-class environmental solution.
"We opted for Epurair(TM) filters because of their innovative and eco-friendly features, which allow us to substantially reduce our filtration inventories and waste and their handling. This filtration solution fits perfectly with our efforts to provide our patients, employees and visitors with a clean, healthy and safe environment and thus improve the efficiency of our medical activities, while enabling us to reduce handling costs," added Michael Boudana, Chief of Plant Operations, JGH.
A 637-bed teaching hospital affiliated with McGill University, the JGH is recognized for its excellent healthcare services and the calibre of its medical staff and research scientists. One of the leading short-term care hospitals in Quebec, the JGH offers general and specialized care to a diversified population and plays a critical role in the Quebec healthcare system. The hospital, which has just celebrated its 75th anniversary, is pursuing its numerous renovation and expansion initiatives in order to maintain the quality and continued improvement of its healthcare and to treat a growing number of people.
Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, including air filters, surgical masks and respirators, along with other products with antibacterial properties such as Microban(R) brand hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to account for new information, new events or new circumstances
SOURCE Noveko International Inc.
For further information: For further information: Chantal Vennat, Director, Investor Relations and Corporate Communications, Noveko International Inc., (514) 875-0606; http://www.noveko.com